University of Colorado Boulder 1002171562

FITC anti-mouse CD8a Antibody; Brilliant Violet 421™ anti-mouse CD3 Antibody; Brilliant Violet 510™ anti-mouse CD19 A...

On August 4, 2025, the University of Colorado Boulder awarded a contract to BioLegend Inc for multiple immunological antibodies, including FITC anti-mouse CD8a, Brilliant Violet 421™ anti-mouse CD3, and others, totaling an obligated amount of $3,129.10. This procurement supports research activities and involves several specific antibody products. The award is a single-transaction purchase with no specified contract end date, carried out at the University of Colorado Boulder located in Boulder, Colorado.

Description

FITC anti-mouse CD8a Antibody; Brilliant Violet 421™ anti-mouse CD3 Antibody; Brilliant Violet 510™ anti-mouse CD19 Antibody; Brilliant Violet 711™ anti-mouse CD8a Antibody; PE/Dazzle™ 594 anti-mouse CD71 Antibody; APC anti-mouse CD4 Antibody; Alexa Fluor® 647 anti-Puromycin Antibody; Brilliant Violet 605™ anti-mouse CD4 Antibody; Brilliant Violet 785™ anti-mouse/human CD45R/B220 Antibody